- Home
- JXN vs ELAN Comparison
JXN vs ELAN Comparison
Compare JXN & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JXN
- ELAN
- Stock Information
- Founded
- JXN 1961
- ELAN 1954
- Country
- JXN United States
- ELAN United States
- Employees
- JXN N/A
- ELAN N/A
- Industry
- JXN Life Insurance
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- JXN Finance
- ELAN Health Care
- Exchange
- JXN Nasdaq
- ELAN Nasdaq
- Market Cap
- JXN 6.8B
- ELAN 7.2B
- IPO Year
- JXN N/A
- ELAN 2018
- Fundamental
- Price
- JXN $97.64
- ELAN $18.53
- Analyst Decision
- JXN Hold
- ELAN Buy
- Analyst Count
- JXN 5
- ELAN 7
- Target Price
- JXN $101.20
- ELAN $17.33
- AVG Volume (30 Days)
- JXN 611.6K
- ELAN 7.1M
- Earning Date
- JXN 08-05-2025
- ELAN 08-07-2025
- Dividend Yield
- JXN 3.26%
- ELAN N/A
- EPS Growth
- JXN N/A
- ELAN N/A
- EPS
- JXN N/A
- ELAN 0.88
- Revenue
- JXN $5,704,000,000.00
- ELAN $4,484,000,000.00
- Revenue This Year
- JXN $115.58
- ELAN $4.44
- Revenue Next Year
- JXN $2.92
- ELAN $4.79
- P/E Ratio
- JXN N/A
- ELAN $21.22
- Revenue Growth
- JXN 29.87
- ELAN N/A
- 52 Week Low
- JXN $64.70
- ELAN $8.02
- 52 Week High
- JXN $115.22
- ELAN $18.87
- Technical
- Relative Strength Index (RSI)
- JXN 62.02
- ELAN 75.67
- Support Level
- JXN $97.16
- ELAN $17.33
- Resistance Level
- JXN $99.61
- ELAN $18.87
- Average True Range (ATR)
- JXN 1.89
- ELAN 0.38
- MACD
- JXN 0.24
- ELAN 0.06
- Stochastic Oscillator
- JXN 78.40
- ELAN 82.83
About JXN Jackson Financial Inc.
Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.